Phase I Study of Random Healthy Donor-Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors

Cancer Immunology Research
Yaewon YangDae Seog Heo

Abstract

Natural killer (NK) cells with mismatched killer cell immunoglobulin-like receptor-ligand pairs have shown efficacy and been proven safe in treatment of cancer patients. Ex vivo-expanded and highly activated NK cells (MG4101) had been generated under good manufacturing practice conditions, which demonstrated potent anticancer activity in vitro and in vivo in preclinical studies. The current phase I clinical trial was designed to evaluate safety and possible clinical efficacy of repetitive administrations of MG4101 derived from random unrelated healthy donors into patients with malignant lymphoma or advanced, recurrent solid tumors. The maximum dose (3 × 10(7) cells/kg, triple infusion) was tolerable without significant adverse events. Of 17 evaluable patients, 8 patients (47.1%) showed stable disease and 9 (52.9%) showed progressive disease. We also evaluated the capacity of MG4101 to influence host immune responses. Administration of MG4101 augmented NKG2D expression on CD8(+) T cells and upregulated chemokines that recruit T cells. In contrast, administration of MG4101 reduced regulatory T cells and myeloid-derived suppressor cells and suppressed TGFβ production. In conclusion, administration of a large number of MG4101 cells...Continue Reading

References

Feb 1, 1992·Tissue Antigens·G BeinH Kirchner
Oct 1, 1987·The Journal of Experimental Medicine·A D Luster, J V Ravetch
Jan 1, 1984·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·A Grieco, C J Long
Nov 8, 2001·Trends in Immunology·M A CooperM A Caligiuri
Mar 11, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Noriko AraseTakashi Saito
Aug 7, 2003·Seminars in Radiation Oncology·Andy TrottiPhilip Rubin
Nov 5, 2003·Trends in Immunology·Per A AlbertssonPeter J K Kuppen
Nov 9, 2004·Nature Immunology·Alfonso Martín-FontechaFederica Sallusto
May 6, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·DeRen HuangRichard M Ransohoff
Jun 8, 2006·Vox Sanguinis·L D Barber, J A Madrigal
Jan 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonUNKNOWN International Harmonization Project on Lymphoma
Dec 17, 2008·Diabetes·Amy L PutnamJeffrey A Bluestone
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Feb 7, 2009·Nature Reviews. Immunology·Dmitry I Gabrilovich, Srinivas Nagaraj
Apr 4, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nathalie T JonckerDavid H Raulet
Aug 13, 2010·Cancer Immunology, Immunotherapy : CII·Eleni G IliopoulouSonia A Perez
Nov 6, 2010·Carcinogenesis·Che LiuJeffrey K Harrison
Mar 24, 2011·Expert Review of Clinical Immunology·Graham P WrightHans J Stauss
Nov 19, 2011·Immunotherapy·Melissa A Geller, Jeffrey S Miller
Mar 26, 2013·Cellular & Molecular Immunology·Isabela Pedroza-PachecoAurore Saudemont
Jul 6, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wing Leung
Sep 3, 2014·Journal of the National Cancer Institute·Antonino BrunoDouglas M Noonan

❮ Previous
Next ❯

Citations

Aug 18, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Inpyo ChoiKyoo-Hyung Lee
Sep 24, 2016·Journal for Immunotherapy of Cancer·Luca Castagna, Domenico Mavilio
Aug 30, 2017·International Journal of Molecular Sciences·Beatriz Martín-AntonioAlvaro Urbano-Ispizua
Feb 2, 2018·International Journal of Cancer. Journal International Du Cancer·Takeshi IshikawaYoshito Itoh
Oct 17, 2019·Cancers·Sooyeon OhSang-Woon Choi
Feb 27, 2020·Journal for Immunotherapy of Cancer·Feng LiYi Zhang
May 18, 2020·Stem Cells Translational Medicine·May Sabry, Mark W Lowdell
May 12, 2017·Frontiers in Immunology·Markus GranzinEvelyn Ullrich
Jul 27, 2018·Frontiers of Medicine·Fang FangZhigang Tian
Jan 23, 2018·Frontiers in Immunology·Locke D UppendahlMelissa A Geller
Feb 26, 2019·Frontiers in Oncology·Gaurav NayyarMitchell S Cairo
Nov 16, 2018·Current Treatment Options in Oncology·Cong Ava FanDana M Roque
Jul 26, 2019·Cancers·Ziqing ChenAndreas Lundqvist
Jun 13, 2020·Frontiers in Immunology·Rih-Sheng HuangSteven Lin
Dec 31, 2017·American Journal of Reproductive Immunology : AJRI·Wenjun WangJianxing He
Jun 19, 2019·International Journal of Molecular Sciences·Eleonora GhisoniGiorgio Valabrega
Sep 25, 2019·Journal of Clinical Medicine·Sizhe LiuJennifer D Wu
Jul 28, 2019·Cancer Research·Dominique C Hinshaw, Lalita A Shevde
Oct 31, 2020·Cancers·Mireia BachillerBeatriz Martín-Antonio
Jan 8, 2021·Journal of Hematology & Oncology·Sizhe LiuJennifer Wu
Feb 20, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Yuanlin WuZhangang Xiao
Apr 10, 2020·Gynecologic Oncology·Janneke S Hoogstad-van EvertHarry Dolstra
Apr 24, 2021·Cancer Gene Therapy·Rakan El-MaytaMichael J Mitchell
May 14, 2021·Cytotherapy·Tewodros MamoDavid H McKenna
May 18, 2021·Therapeutic Advances in Medical Oncology·Apostolos SarivalasisGeorge Coukos
Jun 16, 2021·International Reviews of Immunology·Yi ZhangWei Yang
Jul 9, 2021·Nature Reviews. Genetics·Monica P McNerneyPamela A Silver
Dec 9, 2020·ACS Applied Materials & Interfaces·Kwang-Soo KimKyung-Soon Park
Feb 20, 2018·ACS Applied Materials & Interfaces·Caifeng DingXiliang Luo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.